{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T18:31:36Z","timestamp":1793039496837,"version":"4.5.0"},"reference-count":56,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","internationaljournalofcardiology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Cardiology"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.ijcard.2026.134229","type":"journal-article","created":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T23:30:57Z","timestamp":1770507057000},"page":"134229","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Coronary inflammation: Identification, clinical impact and possible therapeutical solutions"],"prefix":"10.1016","volume":"450","author":[{"given":"Francesco","family":"Prati","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Flavio Giuseppe","family":"Biccir\u00e8","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Teresa","family":"Mallus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Flavio","family":"Mastroianni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Gatto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michela","family":"Ferrari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eloisa","family":"Arbustini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijcard.2026.134229_bb0005","doi-asserted-by":"crossref","first-page":"S55","DOI":"10.1016\/S0002-8703(99)70321-2","article-title":"From plaque biology to clinical setting","volume":"138","author":"Arbustini","year":"1999","journal-title":"Am. Heart J."},{"key":"10.1016\/j.ijcard.2026.134229_bb0010","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1038\/nri1882","article-title":"The immune response in atherosclerosis: a double-edged sword","volume":"6","author":"Hansson","year":"2006","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.ijcard.2026.134229_bb0015","first-page":"389","article-title":"Inflammation and its resolution in atherosclerosis: mediators and therapeutic opportunities","volume":"16","author":"B\u00e4ck","year":"2019","journal-title":"Nat. Rev. Cardiol."},{"key":"10.1016\/j.ijcard.2026.134229_bb0020","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1016\/j.jacc.2011.09.079","article-title":"Consensus standards for acquisition, measurement, and reporting of intravascular optical coherence tomography studies: a report from the International Working Group for Intravascular Optical Coherence Tomography Standardization and Validation","volume":"59","author":"Tearney","year":"2012","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ijcard.2026.134229_bb0025","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1001\/jamacardio.2018.1997","article-title":"Pericoronary adipose tissue computed tomography attenuation and high-risk plaque characteristics in acute coronary syndrome compared with stable coronary artery disease","volume":"3","author":"Goeller","year":"2018","journal-title":"JAMA Cardiol."},{"key":"10.1016\/j.ijcard.2026.134229_bb0030","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1038\/nature08938","article-title":"NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals","volume":"464","author":"Duewell","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.ijcard.2026.134229_bb0035","doi-asserted-by":"crossref","first-page":"E121","DOI":"10.1093\/eurheartj\/suaa076","article-title":"Coronary inflammation: why searching, how to identify and treat it","volume":"22","author":"Prati","year":"2020","journal-title":"Eur. Heart J. Suppl."},{"key":"10.1016\/j.ijcard.2026.134229_bb0040","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1016\/S0140-6736(23)00215-5","article-title":"Inflammation and cholesterol as predictors of cardiovascular events among patients receiving statin therapy: a collaborative analysis of three randomised trials","volume":"401","author":"Ridker","year":"2023","journal-title":"Lancet"},{"key":"10.1016\/j.ijcard.2026.134229_bb0045","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.119.012638","article-title":"hsCRP level and the risk of death or recurrent cardiovascular events in patients with myocardial infarction: a healthcare-based study","volume":"8","author":"Carrero","year":"2019","journal-title":"J. Am. Heart Assoc."},{"key":"10.1016\/j.ijcard.2026.134229_bb0050","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1056\/NEJMoa2405182","article-title":"Inflammation, cholesterol, lipoprotein(a), and 30-year cardiovascular outcomes in women","volume":"391","author":"Ridker","year":"2024","journal-title":"New Engl. J. Med."},{"key":"10.1016\/j.ijcard.2026.134229_bb0055","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.ijcard.2019.01.058","article-title":"Optical coherence tomography and C-reactive protein in risk stratification of acute coronary syndromes","volume":"286","author":"Fracassi","year":"2019","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.ijcard.2026.134229_bb0060","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.atherosclerosis.2020.08.009","article-title":"Macrophage infiltrates in coronary plaque erosion and cardiovascular outcome in patients with acute coronary syndrome","volume":"311","author":"Montone","year":"2020","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.ijcard.2026.134229_bb0065","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1016\/S0140-6736(12)60110-X","article-title":"The interleukin-6 receptor as a target for prevention of coronary heart disease: a mendelian randomisation analysis","volume":"379","author":"Swerdlow","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.ijcard.2026.134229_bb0070","doi-asserted-by":"crossref","first-page":"3499","DOI":"10.1093\/eurheartj\/ehy310","article-title":"Modulation of the interleukin-6 signalling pathway and incidence rates of atherosclerotic events and all-cause mortality: analyses from the Canakinumab Anti-Inflammatory Thrombosis Outcomes Study (CANTOS)","volume":"39","author":"Ridker","year":"2018","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ijcard.2026.134229_bb0075","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1016\/S0140-6736(11)61931-4","article-title":"Interleukin-6 receptor pathways in coronary heart disease: a collaborative meta-analysis of 82 studies","volume":"379","author":"Sarwar","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.ijcard.2026.134229_bb0080","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1056\/NEJMoa035003","article-title":"Prognostic value of myeloperoxidase in patients with chest pain","volume":"349","author":"Brennan","year":"2003","journal-title":"New Engl. J. Med."},{"key":"10.1016\/j.ijcard.2026.134229_bb0085","first-page":"1799","article-title":"Clinical utility of intravascular imaging: past, present, and future","volume":"15","author":"Mintz","year":"2022","journal-title":"J. Am. Coll. Cardiol. Cardiovasc. Imaging."},{"key":"10.1016\/j.ijcard.2026.134229_bb0090","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.ijcard.2018.06.115","article-title":"In vivo vulnerability grading system of plaques causing acute coronary syndromes: an intravascular imaging study","volume":"269","author":"Prati","year":"2018","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.ijcard.2026.134229_bb0095","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1161\/01.CIR.0000044384.41037.43","article-title":"Quantification of macrophage content in atherosclerotic plaques by optical coherence tomography","volume":"107","author":"Tearney","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2026.134229_bb0100","doi-asserted-by":"crossref","first-page":"2513","DOI":"10.1093\/eurheartj\/ehs095","article-title":"Expert review document part 1: methodology, terminology and clinical applications of optical coherence tomography for the assessment of interventional procedures","volume":"33","author":"Prati","year":"2012","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ijcard.2026.134229_bb0105","first-page":"1361","article-title":"Long-term prognostic impact of OCT-derived high-risk plaque features: extended follow-up of the CLIMA study","volume":"18","author":"Biccir\u00e8","year":"2025","journal-title":"J. Am. Coll. Cardiol. Cardiovasc. Interven."},{"key":"10.1016\/j.ijcard.2026.134229_bb0110","doi-asserted-by":"crossref","first-page":"707","DOI":"10.4244\/EIJ-D-23-00628","article-title":"Vulnerable plaque features and adverse events in patients with diabetes mellitus: a post hoc analysis of the COMBINE OCT-FFR trial","volume":"11","author":"Del Val","year":"2024","journal-title":"EuroIntervention"},{"key":"10.1016\/j.ijcard.2026.134229_bb0115","doi-asserted-by":"crossref","first-page":"41","DOI":"10.4244\/EIJ-D-20-01355","article-title":"Artificial intelligence and optical coherence tomography for the automatic characterisation of human atherosclerotic plaques","volume":"17","author":"Chu","year":"2021","journal-title":"EuroIntervention"},{"key":"10.1016\/j.ijcard.2026.134229_bb0120","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.ijcard.2021.11.042","article-title":"Relationship between the amount and location of macrophages and clinical outcome: subanalysis of the CLIMA-study","volume":"346","author":"Gatto","year":"2022","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.ijcard.2026.134229_bb0125","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1007\/s12265-022-10250-z","article-title":"The role of the association between serum C-reactive protein levels and coronary plaque macrophage accumulation in predicting clinical events - results from the CLIMA registry","volume":"15","author":"Budassi","year":"2022","journal-title":"J. Cardiovasc. Transl. Res."},{"key":"10.1016\/j.ijcard.2026.134229_bb0130","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1001\/jama.2022.5218","article-title":"Effect of alirocumab added to high-intensity statin therapy on coronary atherosclerosis in patients with acute myocardial infarction: the PACMAN-AMI randomized clinical trial","volume":"327","author":"R\u00e4ber","year":"2022","journal-title":"JAMA"},{"key":"10.1016\/j.ijcard.2026.134229_bb0135","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1016\/j.jcmg.2016.01.034","article-title":"Targeted near-infrared fluorescence imaging of atherosclerosis: clinical and intracoronary evaluation of Indocyanine green","volume":"9","author":"Verjans","year":"2016","journal-title":"JACC Cardiovasc. Imaging"},{"key":"10.1016\/j.ijcard.2026.134229_bb0140","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/s10554-014-0556-z","article-title":"Dual modality intravascular optical coherence tomography (OCT) and near-infrared fluorescence (NIRF) imaging: a fully automated algorithm for the distance-calibration of NIRF signal intensity for quantitative molecular imaging","volume":"31","author":"Ughi","year":"2015","journal-title":"Int. J. Cardiovasc. Imaging"},{"key":"10.1016\/j.ijcard.2026.134229_bb0145","doi-asserted-by":"crossref","first-page":"2708","DOI":"10.1161\/01.CIR.0000020548.60110.76","article-title":"Imaging atherosclerotic plaque inflammation with [18F]-fluorodeoxyglucose positron emission tomography","volume":"105","author":"Rudd","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2026.134229_bb0150","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1016\/j.jacc.2017.01.060","article-title":"Detection of atherosclerotic inflammation by (68)Ga-DOTATATE PET compared to [(18)F]FDG PET imaging","volume":"69","author":"Tarkin","year":"2017","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ijcard.2026.134229_bb0155","doi-asserted-by":"crossref","first-page":"499","DOI":"10.3945\/ajcn.2008.27358","article-title":"The association of pericardial fat with incident coronary heart disease: the Multi-Ethnic Study of Atherosclerosis (MESA)","volume":"90","author":"Ding","year":"2009","journal-title":"Am. J. Clin. Nutr."},{"key":"10.1016\/j.ijcard.2026.134229_bb0160","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/S0140-6736(18)31114-0","article-title":"Non-invasive detection of coronary inflammation using computed tomography and prediction of residual cardiovascular risk (the CRISP CT study): a post-hoc analysis of prospective outcome data","volume":"392","author":"Oikonomou","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.ijcard.2026.134229_bb0165","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCIMAGING.119.009829","article-title":"Deep learning-based quantification of epicardial adipose tissue volume and attenuation predicts major adverse cardiovascular events in asymptomatic subjects","volume":"13","author":"Eisenberg","year":"2020","journal-title":"Circulation Cardiovasc. Imaging"},{"key":"10.1016\/j.ijcard.2026.134229_bb0170","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1016\/j.jcmg.2025.04.008","article-title":"Association of pericoronary adipose attenuation with major adverse cardiovascular events and high-risk plaque","volume":"18","author":"Tan","year":"2025","journal-title":"JACC Cardiovasc. Imaging"},{"key":"10.1016\/j.ijcard.2026.134229_bb0175","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1016\/j.echo.2009.10.013","article-title":"Echocardiographic epicardial fat: a review of research and clinical applications","volume":"22","author":"Iacobellis","year":"2009","journal-title":"J. Am. Soc. Echocardiogr."},{"key":"10.1016\/j.ijcard.2026.134229_bb0180","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.echo.2010.11.008","article-title":"Epicardial fat: an additional measurement for subclinical atherosclerosis and cardiovascular risk stratification?","volume":"24","author":"Nelson","year":"2011","journal-title":"J. Am. Soc. Echocardiogr."},{"key":"10.1016\/j.ijcard.2026.134229_bb0185","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1007\/s11883-024-01241-3","article-title":"Targeting inflammatory pathways in atherosclerosis: exploring new opportunities for treatment","volume":"26","author":"d\u2019Aiello","year":"2024","journal-title":"Curr. Atheroscler. Rep."},{"key":"10.1016\/j.ijcard.2026.134229_bb0190","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1056\/NEJMoa2021372","article-title":"Colchicine in patients with chronic coronary disease","volume":"383","author":"Nidorf","year":"2020","journal-title":"New Engl. J. Med."},{"key":"10.1016\/j.ijcard.2026.134229_bb0195","doi-asserted-by":"crossref","first-page":"2497","DOI":"10.1056\/NEJMoa1912388","article-title":"Efficacy and safety of low-dose colchicine after myocardial infarction","volume":"381","author":"Tardif","year":"2019","journal-title":"New Engl. J. Med."},{"key":"10.1016\/j.ijcard.2026.134229_bb0200","doi-asserted-by":"crossref","first-page":"3415","DOI":"10.1093\/eurheartj\/ehae177","article-title":"2024 ESC guidelines for the management of chronic coronary syndromes","volume":"45","author":"Vrints","year":"2024","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ijcard.2026.134229_bb0205","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1056\/NEJMoa2405922","article-title":"Colchicine in acute myocardial infarction","volume":"392","author":"Jolly","year":"2025","journal-title":"New Engl. J. Med."},{"key":"10.1016\/j.ijcard.2026.134229_bb0210","doi-asserted-by":"crossref","first-page":"2564","DOI":"10.1093\/eurheartj\/ehaf210","article-title":"Colchicine for secondary prevention of vascular events: a meta-analysis of trials","volume":"46","author":"d\u2019Entremont","year":"2025","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ijcard.2026.134229_bb0215","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijcard.2025.133045","article-title":"Colchicine for secondary prevention in patients with acute coronary syndrome: a systematic review and meta-analysis","volume":"425","author":"Shaikh","year":"2025","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.ijcard.2026.134229_bb0220","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1093\/cvr\/cvae191","article-title":"Optical coherence tomography assessment of the impact of colchicine on non-culprit coronary plaque composition after myocardial infarction","volume":"121","author":"Psaltis","year":"2025","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.ijcard.2026.134229_bb0225","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1161\/CIRCULATIONAHA.124.069808","article-title":"Effect of colchicine on coronary plaque stability in acute coronary syndrome as assessed by optical coherence tomography: the COLOCT randomized clinical trial","volume":"150","author":"Yu","year":"2024","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2026.134229_bb0230","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1056\/NEJMoa1707914","article-title":"Antiinflammatory therapy with canakinumab for atherosclerotic disease","volume":"377","author":"Ridker","year":"2017","journal-title":"New Engl. J. Med."},{"key":"10.1016\/j.ijcard.2026.134229_bb0235","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/S0140-6736(17)32814-3","article-title":"Relationship of C-reactive protein reduction to cardiovascular event reduction following treatment with canakinumab: a secondary analysis from the CANTOS randomised controlled trial","volume":"391","author":"Ridker","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.ijcard.2026.134229_bb0240","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1093\/ehjcvp\/pvab075","article-title":"Interleukin-1 blockade with anakinra and heart failure following ST-segment elevation myocardial infarction: results from a pooled analysis of the VCUART clinical trials","volume":"8","author":"Abbate","year":"2022","journal-title":"Eur. Heart J. Cardiovasc. Pharmacother."},{"key":"10.1016\/j.ijcard.2026.134229_bb0245","doi-asserted-by":"crossref","first-page":"2060","DOI":"10.1016\/S0140-6736(21)00520-1","article-title":"IL-6 inhibition with ziltivekimab in patients at high atherosclerotic risk (RESCUE): a double-blind, randomised, placebo-controlled, phase 2 trial","volume":"397","author":"Ridker","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.ijcard.2026.134229_bb0250","doi-asserted-by":"crossref","first-page":"2328","DOI":"10.1038\/s41591-024-03043-1","article-title":"IL-6 inhibition with clazakizumab in patients receiving maintenance dialysis: a randomized phase 2b trial","volume":"30","author":"Chertow","year":"2024","journal-title":"Nat. Med."},{"key":"10.1016\/j.ijcard.2026.134229_bb0255","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1056\/NEJMoa1809798","article-title":"Low-dose methotrexate for the prevention of atherosclerotic events","volume":"380","author":"Ridker","year":"2018","journal-title":"New Engl. J. Med."},{"key":"10.1016\/j.ijcard.2026.134229_bb0260","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1001\/jamacardio.2024.3200","article-title":"Lesion-level effects of LDL-C-lowering therapy in patients with acute myocardial infarction: a post hoc analysis of the PACMAN-AMI trial","volume":"9","author":"Biccir\u00e8","year":"2024","journal-title":"JAMA Cardiol."},{"key":"10.1016\/j.ijcard.2026.134229_bb0265","article-title":"OxLDL-targeted chimeric antigen receptor T regulatory cells reduce atherosclerotic plaque development","volume":"21","author":"Schwab","year":"2025","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2026.134229_bb0270","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.1056\/NEJMoa2307563","article-title":"Semaglutide and cardiovascular outcomes in obesity without diabetes","volume":"389","author":"Lincoff","year":"2023","journal-title":"New Engl. J. Med."},{"key":"10.1016\/j.ijcard.2026.134229_bb0275","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.ahj.2025.05.001","article-title":"Effect of once-weekly subcutaneous semaglutide on arterial inflammation in people with type 2 diabetes and cardiovascular disease using PET-MRI: primary results of a randomized, double-blind, placebo-controlled trial","volume":"289","author":"James","year":"2025","journal-title":"Am. Heart J."},{"key":"10.1016\/j.ijcard.2026.134229_bb0280","article-title":"Anti-oxidized LDL antibodies and coronary artery disease: a systematic review","volume":"8","author":"van den Berg","year":"2019","journal-title":"Antioxidants (Basel, Switzerland)."}],"container-title":["International Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016752732600077X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016752732600077X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,2,28]],"date-time":"2026-02-28T17:37:45Z","timestamp":1772300265000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S016752732600077X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":56,"alternative-id":["S016752732600077X"],"URL":"https:\/\/doi.org\/10.1016\/j.ijcard.2026.134229","relation":{},"ISSN":["0167-5273"],"issn-type":[{"value":"0167-5273","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Coronary inflammation: Identification, clinical impact and possible therapeutical solutions","name":"articletitle","label":"Article Title"},{"value":"International Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijcard.2026.134229","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"134229"}}